West Pharmaceutical Services, an Exton, Pennsylvania-headquartered manufacturer of packaging and delivery systems for injectable drugs and healthcare products, is launching two new extensions of its SmartDose drug-delivery platform, designed for single-use administration of injectable drugs.

The product extensions include: SmartDose Gen. II, a system that can accommodate injection volumes of up to 10 mL, as well as both glass and Daikyo Crystal Zenith containers; and SmartDose Gen. III, a preloaded version, which reduces user steps and simplifies supply chain.

West’s SmartDose drug-delivery platform allows patients to self-administer medication in accordance with their prescribed treatment, according to the company. West developed the wearable device with human-factors testing and analysis to understand the interaction between the patient and the delivery system. All versions of the SmartDose platform adhere to the patient’s body, usually on the abdomen, so patients can be hands-free during administration.

Source: West Pharmaceutical Services